XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 29, 2025
Jun. 30, 2024
Operating activities:    
Net income $ 96,185 $ 81,373
Loss from discontinued operations, net of income taxes 706 19,929
Income from continuing operations 96,891 101,302
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:    
Restructuring and other costs, net 14,442 22,201
Depreciation and amortization 200,200 215,146
Stock-based compensation 17,864 22,218
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) (166) 6,349
Amortization of deferred debt financing costs and accretion of discounts 2,320 3,509
Change in fair value of financial securities (1,118) (6,971)
Unrealized Foreign Exchange (Gain) Loss Related to Proceed from Sale of Business 140 (857)
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:    
Accounts receivable, net (21,901) 28,194
Inventories 5,642 17,251
Accounts payable 3,278 (22,974)
Increase (Decrease) in Accrued Expenses and Other (49,177) (52,894)
Net cash provided by operating activities of continuing operations 268,415 332,474
Net cash used in operating activities of discontinued operations (5,942) (26,290)
Net cash provided by operating activities 262,473 306,184
Investing activities:    
Capital expenditures (34,850) (39,875)
Purchases of investments and notes receivables 0 (4,337)
Proceeds from Divestiture of Businesses 229 0
Net cash used in investing activities of continuing operations (34,621) (44,212)
Net cash provided by investing activities of discontinued operations 18,750 147,522
Net cash (used in) provided by investing activities (15,871) 103,310
Financing activities:    
Payments of debt financing issuance costs (2,474) 0
Net payments on other credit facilities (103) (11,200)
Payment for Contingent Consideration Liability, Financing Activities (1,978) (8,749)
Proceeds from issuance of common stock under stock plans 2,632 6,032
Purchases of common stock (447,501) (30,309)
Dividends paid (16,715) (17,282)
Net cash used in financing activities (466,139) (61,508)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48,075 (12,931)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent (171,462) 335,055
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period 1,164,452 914,373
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period 992,990 1,249,428
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 991,849 1,248,120
Restricted Cash, Current 1,141 1,308
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 992,990 $ 1,249,428